Exploring the Immunomodulatory Effects of an Immune Checkpoint Inhibitor (Agonistic Anti-Cd40/ Cd40 Ligand) for the Treatment of Hepatocellular Carcinoma, Including Therapeutic Implications

2022-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/690168Exploring the Immunomodulatory Effects of an Immune Checkpoint Inhibitor (Agonistic Anti-Cd40/ Cd40 Ligand) for the Treatment of Hepatocellular Carcinoma, Including Therapeutic Implications